Literature DB >> 1901729

Phosphorylase b kinase and phosphorylase a phosphatase activities in contracting vascular smooth muscle: stimulation by fatty acid.

J T Barron1, S J Kopp.   

Abstract

The activities of phosphorylase b kinase and phosphorylase a phosphatase were determined during the phases of KCl-induced contraction in porcine carotid artery. Phosphorylase b kinase exhibited a biphasic pattern with activity increasing 70% above basal levels during the early phase of active force generation (45 s into contraction) followed by a decline in activity during the phase of steady-state tension maintenance. Phosphorylase a phosphatase was stimulated simultaneously with phosphorylase b kinase, with activity increasing 100% over basal levels at 45 s into contraction, but remaining elevated at 30 min. Incubation of arteries in 0.5 mM palmitate resulted in a 30% increase in basal activity of phosphorylase b kinase and 117% augmentation of basal phosphatase activity, with no further increase in activity of either enzyme with contraction. The results indicate that both the kinase and phosphatase are subject to regulation during contractile activation of the muscle, possibly by similar but not identical mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901729     DOI: 10.1016/0304-4165(91)90229-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Relation of NADH/NAD to contraction in vascular smooth muscle.

Authors:  J T Barron; L Gu; J E Parrillo
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

2.  Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: Role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake.

Authors:  Rajkumar Pyla; Prahalathan Pichavaram; Arwa Fairaq; Mary Anne Park; Mark Kozak; Vinayak Kamath; Vijay S Patel; Lakshman Segar
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.